rac-(3aS,7aR)-hexahydro[1,3]oxazolo[4,5-c]pyridin-2(3H)-one hydrochloride, 95.0%, 250mg

3-Bromo-2-methylpropanoic acid, 95.0%, 5g

Tetrakis(3-bromophenyl)silane>98.0%(GC)1g

Citalopram Hydrobromide>98.0%(HPLC)(T)1g

6-Ethoxypyridine-2-carboxylic acid, 97.0%, 1g

N,N-Dicyclohexylmethylamine>98.0%(GC)(T)100mL

2-(4-Hydroxyphenyl)-4-methyl-thiazole-5-carboxylic acid ethyl ester, 97.0%, 100g

4-(4-Hydroxypiperidin-4-yl)benzonitrile hydrochloride, 97.0%, 100mg

(E)-3-(6-METHYL-1H-INDOL-3-YL)ACRYLIC ACID, 95.0%, 250mg

(S)-TETRAHYDROFURAN-3-YL ((2S,3R)-4-(4-AMINO-N-ISOBUTYLPHENYLSULFONAMIDO)-1-PHENYL-3-(PHOSPHONOOXY)BUTAN-2-YL)CARBAMATE, 99%, 100mg

4-Chloro-3-fluoropyridine-2-carboxylic acid, 97%, 10g

ethyl 3-(hexylamino)propanoate, 95.0%, 10g

Adamantanol, min. 99%, for synthesis, 50 g, glass packaging